ArticleCureus2026
A Comparative Analysis of Clinical Features of Type 2 Diabetes Mellitus With Respect to Dyslipidemia: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes mellitus type 2 is frequently associated with dyslipidemia, which accelerates cardiovascular risk and worsens metabolic control. Understanding how clinical features differ between patients with diabetes with and without dyslipidemia is essential for early identification of high-risk individuals.
objectiveTo compare the clinical features of patients with type 2 diabetes who have dyslipidemia and those who do not, to identify any important differences in their health patterns.
methodsThis cross-sectional study was conducted over six months (March-August 2024) at multiple secondary and primary care centers in Karachi, Pakistan, with ethical approval from Sindh Government Hospital, Malir (Approval No. 1477). A total of 340 patients aged 30-75 years were enrolled, divided equally into dyslipidemic (Group A) and non-dyslipidemic (Group B) groups. The chi-square test and an independent t-test were used to examine associations between categorical and continuous variables. Pearson's chi-square statistic, degrees of freedom, and p-values were obtained. Effect size was calculated using Cramer's V to determine the strength of association.
resultsThe dyslipidemia group showed distinct demographic patterns with male predominance (117 (68.8%), p < 0.001), higher smoking prevalence (45.3% vs 17.1%, p < 0.001), and lower physical activity levels (61.2% vs 73.5%, p = 0.015). These patients were significantly older (60.0 ± 15.85 vs 53.51 ± 14.40 years, p < 0.001) and had greater weight (72.05 ± 13.07 vs 66.90 ± 16.01 kg, p = 0.001). Clinical symptoms were more prevalent among dyslipidemic patients, including frequent urination (99 (58.2%) vs 46 (27.1%), p < 0.001), visual impairment (104 (61.2%) vs 72 (42.4%), p = 0.001), and blurred vision (78 (45.9%) vs 47 (27.6%), p < 0.001).
conclusionThis study concluded that patients with type 2 diabetes mellitus and dyslipidemia had a higher prevalence of visual disturbances, urinary symptoms, fatigue, musculoskeletal pain, and other systemic complaints compared with non-dyslipidemic patients. Significant differences were observed in blurred vision, chest discomfort, increased thirst, fatigue, and mood changes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.